Carcinosarcomas (also known as malignant mixed müllerian tumors) are rare and highly
aggressive epithelial malignancies that contain both malignant sarcomatous and …

Objective The objective of this study was to provide a consensus review on gestational
trophoblastic disease diagnosis and management from the combined International Society …

Most women diagnosed with malignant ovarian germ cell tumors have curable disease and
experience excellent survival with manageable treatment-associated morbidity, related both …

Background Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, has previously
shown efficacy in a phase 2 study when given in capsule formulation to all-comer patients …

Background Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, has previously
been shown to extend progression-free survival versus placebo when given to patients with …

Background Treatment for patients with recurrent ovarian cancer has been mainly based on
systemic therapy. The role of secondary cytoreductive surgery is unclear. Methods We …

Background Systematic pelvic and paraaortic lymphadenectomy has been widely used in
the surgical treatment of patients with advanced ovarian cancer, although supporting …

Purpose Pazopanib is an oral, multikinase inhibitor of vascular endothelial growth factor
receptor (VEGFR)-1/-2/-3, platelet-derived growth factor receptor (PDGFR)-α/-β, and c-Kit …

Background Secondary surgical cytoreduction in women with platinum-sensitive, recurrent
epithelial ovarian, primary peritoneal, or fallopian-tube (“ovarian”) cancer is widely practiced …

PURPOSE The primary objective was to determine if vaginal cuff brachytherapy and
chemotherapy (VCB/C) increases recurrence-free survival (RFS) compared with pelvic …